JPM advised Organigram Holdings Inc., the parent company of Organigram Inc., a leading licensed producer of medical marijuana in Canada, on the private placement investment in Eviana Health Corporation. Organigram along with an institutional strategic investor each participated 50% in a 10 million dollars debenture offering by Eviana.

Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada, with Organigram developing a portfolio of brands including The Edison Cannabis Company, Ankr Organics, Trailblazer and Trailer Park Buds.

Eviana is present in the Serbian market by being the only shareholder of the company Intiva Plus doo Dobanovci, which holds certain licenses authorizing the growing of industrial hemp in Serbia and is one of the biggest manufacturers therein.

JPM advised Organigram Holdings Inc. on the legal aspects and the framework of the transaction in Serbia and performed a due diligence of the Serbian company’s business.
Senior partner Nenad Popović and senior associate Bojana Javorić led this project on behalf of JPM.